Flarex Suspension/ Drops
FDA Label NDC 71776-100

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Eyevance Pharmaceuticals for the product Flarex (NDC 71776-100). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Manufactured for:

Eyevance Pharmaceuticals, LLC

Fort Worth, TX  76102 USA

* Please review the disclaimer below.